Ebola as a case study for the patent landscape of medical countermeasures for emerging infectious diseases

Related Experiment Video

Updated: Oct 29, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.3K

Nasir Mohajel1, Arash Arashkia2

  • 1Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran. n_mohajel@pasteur.ac.ir.

Nature Biotechnology
|July 14, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.6K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.5K

Related Experiment Videos

Last Updated: Oct 29, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.3K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.6K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.5K

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

266
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
266
Cross-reactivity00:42

Cross-reactivity

31.8K
Overview
31.8K

Articles linked to this work by shared authors, journal, and citation graph.

mRNA vaccines targeting HPV E6/E7: A new frontier in cervical cancer immunotherapy.

Critical reviews in oncology/hematology·2026

Expression of the switch receptor PD1/IL15Rβ in MSLN-CAR-T cells overcomes PD1/PDL1 signaling in solid tumors.

Scientific reports·2026

Molecular Epidemiology of Human Adenovirus Strains in Children With Acute Gastroenteritis in Tehran, Iran (2021-2022 and 2023-2024): Genetic Characterization of Adenovirus F41.

Health science reports·2026

PD-1: CD28 chimeric receptors enhance phenotypic and functional features of T cell subsets.

Research in pharmaceutical sciences·2026

The rotavirus cVLPVP8∗ vaccine candidate induces cross-genotype/heterotypic neutralizing antibody responses against human rotavirus G9P[4].

Virology·2026

Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer.

Retrovirology·2026

An mRNA-lipid nanoparticle vaccine against H5N1 influenza virus protects lactating dairy cows from infection.

Nature biotechnology·2026

An engineered, compact Cas12m variant for multiplexed gene activation in vivo.

Nature biotechnology·2026

Recordanelles for transcriptome-wide single-cell RNA recording in human cells.

Nature biotechnology·2026

Deep dynamical models of single-cell multiomic velocities predict loss-of-function and rescue perturbations in B cells.

Nature biotechnology·2026

Genetic code expansion enables plant-directed control of bacterial activity.

Nature biotechnology·2026

Engineered human Argonaute 2 for targeted C-to-U RNA base editing.

Nature biotechnology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us